 |
PDBsum entry 2qhm
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.11.1
- non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Bioorg Med Chem Lett
17:5989-5994
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Optimization of a pyrazoloquinolinone class of Chk1 kinase inhibitors.
|
|
E.J.Brnardic,
R.M.Garbaccio,
M.E.Fraley,
E.S.Tasber,
J.T.Steen,
K.L.Arrington,
V.Y.Dudkin,
G.D.Hartman,
S.M.Stirdivant,
B.A.Drakas,
K.Rickert,
E.S.Walsh,
K.Hamilton,
C.A.Buser,
J.Hardwick,
W.Tao,
S.C.Beck,
X.Mao,
R.B.Lobell,
L.Sepp-Lorenzino,
Y.Yan,
M.Ikuta,
S.K.Munshi,
L.C.Kuo,
C.Kreatsoulas.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The development of 2,5-dihydro-4H-pyrazolo[4,3-c]quinolin-4-ones as inhibitors
of Chk1 kinase is described. Introduction of a fused ring at the C7/C8 positions
of the pyrazoloquinolinone provided an increase in potency while guidance from
overlapping inhibitor bound Chk1 X-ray crystal structures contributed to the
discovery of a potent and solubilizing propyl amine moiety in compound 52 (Chk1
IC(50)=3.1 nM).
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
X.M.Chen,
T.Lu,
S.Lu,
H.F.Li,
H.L.Yuan,
T.Ran,
H.C.Liu,
and
Y.D.Chen
(2010).
Structure-based and shape-complemented pharmacophore modeling for the discovery of novel checkpoint kinase 1 inhibitors.
|
| |
J Mol Model,
16,
1195-1204.
|
 |
|
|
|
|
 |
A.G.Villaseñor,
R.Kondru,
H.Ho,
S.Wang,
E.Papp,
D.Shaw,
J.W.Barnett,
M.F.Browner,
and
A.Kuglstatter
(2009).
Structural insights for design of potent spleen tyrosine kinase inhibitors from crystallographic analysis of three inhibitor complexes.
|
| |
Chem Biol Drug Des,
73,
466-470.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |